Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 418 shares at $71.98 ($30K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Seasonal sale ($30k) by President & CEO — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |
| NKTR | SELL | 2025-09-11 | $528K | — | Filing → |